Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through

M Y Cherepkova1, G S Sineva1, V A Pospelov1

  • 1Laboratory of Molecular Mechanisms Cell Differentiation, Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

Cell Death & Disease
|January 19, 2016
PubMed

Insights

Leukemia inhibitory factor (LIF) maintains mouse embryonic stem cell (ESC) pluripotency by suppressing mTOR signaling via the STAT3 pathway. LIF withdrawal activates mTOR and ERK, promoting differentiation.

Area of Science:

  • Stem cell biology
  • Molecular signaling pathways
  • Cellular differentiation

Background:

  • Leukemia inhibitory factor (LIF) is crucial for maintaining the pluripotency of mouse embryonic stem cells (ESCs).
  • The precise molecular mechanisms by which the LIF/STAT3 pathway regulates ESC self-renewal and pluripotency remain incompletely understood.
  • Mammalian target of rapamycin (mTOR) signaling is implicated in cellular differentiation processes.

Purpose of the Study:

  • To elucidate the role of the LIF/STAT3 signaling pathway in maintaining mouse ESC pluripotency.
  • To investigate the relationship between LIF/STAT3 signaling and mTOR activity in ESCs.
  • To understand the molecular events leading to ESC differentiation upon LIF withdrawal.

Main Methods:

  • Western blotting to detect protein phosphorylation (e.g., S6, 4EBP1, STAT3, ERK, TSC2).
  • Treatment of ESCs with LIF, LIF withdrawal, and specific small molecule inhibitors (e.g., WP1066).
  • Quantitative analysis of gene expression for pluripotency markers (Oct-4, Nanog, Sox2) and differentiation markers (fgf5).

Main Results:

  • LIF withdrawal rapidly increased mTOR activity, evidenced by increased phosphorylation of its targets S6 and 4EBP1.
  • Suppression of STAT3 phosphorylation also led to mTOR activation.
  • LIF withdrawal activated ERK signaling and caused phosphorylation of TSC2, relieving its inhibition on mTOR.
  • mTOR activation correlated with decreased expression of pluripotency genes (Oct-4, Nanog, Sox2) and increased expression of the differentiation marker fgf5.

Conclusions:

  • The LIF/STAT3 pathway maintains mouse ESC pluripotency by suppressing mTOR signaling.
  • LIF withdrawal triggers a transition from a pluripotent state to a primed-like state via mTOR activation and ERK signaling.
  • This transition involves the downregulation of key pluripotency factors and upregulation of early differentiation markers.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K